{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:28:14Z","timestamp":1761611294905,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T00:00:00Z","timestamp":1599350400000},"content-version":"vor","delay-in-days":3019,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular &amp; Cellular Proteomics"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1074\/mcp.m111.013417","type":"journal-article","created":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T20:43:04Z","timestamp":1325018584000},"page":"M111.013417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Pharmacoproteomic Study of Three Different Chondroitin Sulfate Compounds on Intracellular and Extracellular Human Chondrocyte Proteomes"],"prefix":"10.1016","volume":"11","author":[{"given":"Valentina","family":"Calamia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Fern\u00e1ndez-Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Lourido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eul\u00e1lia","family":"Montell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Verg\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ruiz-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.M111.013417_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1586\/epr.10.27","article-title":"Proteomics of osteoarthritic chondrocytes and cartilage","volume":"7","author":"Iliopoulos","year":"2010","journal-title":"Expert Rev. Proteomics"},{"key":"10.1074\/mcp.M111.013417_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcp.2010.02.017","article-title":"New molecular targets for the treatment of osteoarthritis","volume":"80","author":"Alcaraz","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1074\/mcp.M111.013417_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2474-9-165","article-title":"Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system","volume":"9","author":"Bruy\u00e8re","year":"2008","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1074\/mcp.M111.013417_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.joca.2010.10.017","article-title":"Nutraceuticals: Do they represent a new era in the management of osteoarthritis? A narrative review from the lessons taken with five products","volume":"19","author":"Henrotin","year":"2011","journal-title":"Osteoarthr. Cartil."},{"key":"10.1074\/mcp.M111.013417_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1271\/bbb.80418","article-title":"Effects of an oral administration of glucosamine-chondroitin-quercetin glucoside on the synovial fluid properties in patients with osteoarthritis and rheumatoid arthritis","volume":"73","author":"Matsuno","year":"2009","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1074\/mcp.M111.013417_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/art.24302","article-title":"Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: Role of p38 and Akt","volume":"60","author":"David-Raoudi","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1074\/mcp.M111.013417_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/ard.2006.068882","article-title":"Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues","volume":"67","author":"Monfort","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1074\/mcp.M111.013417_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3899\/jrheum.090696","article-title":"Variable effects of 3 different chondroitin sulfate compounds on human osteoarthritic cartilage\/chondrocytes: Relevance of purity and production process","volume":"37","author":"Tat","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1074\/mcp.M111.013417_bib9","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.283.11.1469","article-title":"Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and meta-analysis","volume":"283","author":"McAlindon","year":"2000","journal-title":"JAMA."},{"key":"10.1074\/mcp.M111.013417_bib10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis","volume":"354","author":"Clegg","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/mcp.M111.013417_bib11","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1002\/pmic.200402106","article-title":"Proteomic characterization of human normal articular chondrocytes: A novel tool for the study of osteoarthritis and other rheumatic diseases","volume":"5","author":"Ruiz-Romero","year":"2005","journal-title":"Proteomics."},{"key":"10.1074\/mcp.M111.013417_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.joca.2005.12.004","article-title":"Mitochondrial proteomic characterization of human normal articular chondrocytes","volume":"14","author":"Ruiz-Romero","year":"2006","journal-title":"Osteoarthr. Cartil."},{"key":"10.1074\/mcp.M111.013417_bib13","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/ar3077","article-title":"Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes","volume":"12","author":"Calamia","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1074\/mcp.M111.013417_bib14","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1021\/ac9806005","article-title":"Modification of cysteine residues by alkylation: A tool in peptide mapping and protein identification","volume":"70","author":"Sechi","year":"1998","journal-title":"Anal. Chem."},{"key":"10.1074\/mcp.M111.013417_bib15","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1021\/pr200331k","article-title":"Metabolic labeling of chondrocytes for the quantitative analysis of the interleukin-1-\u03b2-mediated modulation of their intracellular and extracellular proteomes","volume":"10","author":"Calamia","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1074\/mcp.M111.013417_bib16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/pmic.200700249","article-title":"Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis","volume":"8","author":"Ruiz-Romero","year":"2008","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M111.013417_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1074\/mcp.M800292-MCP200","article-title":"Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: A decrease in mitochondrial superoxide dismutase points to a redox imbalance","volume":"8","author":"Ruiz-Romero","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M111.013417_bib18","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1021\/pr200695p","article-title":"Identification of a panel of novel serum osteoarthritis biomarkers","volume":"10","author":"Fern\u00e1ndez-Puente","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1074\/mcp.M111.013417_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14789450.4.2.239","article-title":"Approaches to the study of the cell secretome","volume":"4","author":"Hathout","year":"2007","journal-title":"Exp. Rev. Proteomics"},{"key":"10.1074\/mcp.M111.013417_bib20","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/1522-2683(20000601)21:11<2099::AID-ELPS2099>3.0.CO;2-N","article-title":"Proteomics: Applications and opportunities in preclinical drug development","volume":"21","author":"Steiner","year":"2000","journal-title":"Electrophoresis"},{"key":"10.1074\/mcp.M111.013417_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.tpj.6500164","article-title":"Pharmacoproteomics in drug development","volume":"3","author":"Witzmann","year":"2003","journal-title":"Pharmacogenomics J."},{"key":"10.1074\/mcp.M111.013417_bib22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/art.27265","article-title":"Proteomic analysis by two-dimensional electrophoresis to identify the normal human chondrocyte proteome stimulated by tumor necrosis factor \u03b1 and interleukin-1\u03b2","volume":"62","author":"Cillero-Pastor","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1074\/mcp.M111.013417_bib23","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1021\/pr901209s","article-title":"Hypoxia conditions differentially modulate human normal and osteoarthritic chondrocyte proteomes","volume":"9","author":"Ruiz-Romero","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1074\/mcp.M111.013417_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/sarh.2000.24874","article-title":"Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system","volume":"31","author":"Bali","year":"2001","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1074\/mcp.M111.013417_bib25","doi-asserted-by":"crossref","first-page":"15892","DOI":"10.1074\/jbc.274.22.15892","article-title":"Sulfation of chondroitin sulfate in human articular cartilage: The effect of age, topographical position, and zone of cartilage on tissue composition","volume":"274","author":"Bayliss","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1074\/mcp.M111.013417_bib26","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1211\/jpp.61.10.0002","article-title":"Quality of different chondroitin sulfate preparations in relation to their therapeutic activity","volume":"61","author":"Volpi","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1074\/mcp.M111.013417_bib27","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/jps.20997","article-title":"Analytical aspects of pharmaceutical grade chondroitin sulfates","volume":"96","author":"Volpi","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1074\/mcp.M111.013417_bib28","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1053\/joca.2002.0824","article-title":"Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers","volume":"10","author":"Volpi","year":"2002","journal-title":"Osteoarthr. Cartil."},{"key":"10.1074\/mcp.M111.013417_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1063-4584(03)00051-7","article-title":"Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers","volume":"11","author":"Volpi","year":"2003","journal-title":"Osteoarthr. Cartil."},{"issue":"Suppl. A","key":"10.1074\/mcp.M111.013417_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1063-4584(98)80006-X","article-title":"Anti-inflammatory activity of chondroitin sulfate","volume":"6","author":"Ronca","year":"1998","journal-title":"Osteoarthr. Cartil."},{"key":"10.1074\/mcp.M111.013417_bib31","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1211\/jpp.61.10.0001","article-title":"Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: A critique","volume":"61","author":"Rainsford","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1074\/mcp.M111.013417_bib32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","article-title":"Long-term effects of glucosamine sulphate on osteoarthritis progression: A randomised, placebo-controlled clinical trial","volume":"357","author":"Reginster","year":"2001","journal-title":"Lancet"},{"key":"10.1074\/mcp.M111.013417_bib33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s11926-000-0023-9","article-title":"Evidence of nutriceutical effectiveness in the treatment of osteoarthritis","volume":"2","author":"Reginster","year":"2000","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1074\/mcp.M111.013417_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1359-6446(03)02980-5","article-title":"Biological basis for the benefit of nutraceutical supplementation in arthritis","volume":"9","author":"Curtis","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1074\/mcp.M111.013417_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1054-3589(05)53020-5","article-title":"Antioxidant activity of chondroitin sulfate","volume":"53","author":"Campo","year":"2006","journal-title":"Adv. Pharmacol."},{"key":"10.1074\/mcp.M111.013417_bib36","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2174\/138955707782110088","article-title":"Symptom and structure modifying properties of chondroitin sulfate in osteoarthritis","volume":"7","author":"Reginster","year":"2007","journal-title":"Mini. Rev. Med. Chem."},{"key":"10.1074\/mcp.M111.013417_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jcb.21981","article-title":"Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes","volume":"106","author":"Campo","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1074\/mcp.M111.013417_bib38","doi-asserted-by":"crossref","first-page":"e2267","DOI":"10.1371\/journal.pone.0002267","article-title":"Pharmacological inhibition of nicotinamide phosphoribosyltransferase\/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD","volume":"3","author":"Busso","year":"2008","journal-title":"PLoS One"},{"key":"10.1074\/mcp.M111.013417_bib39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1196\/annals.1422.041","article-title":"Cartilage oligomeric matrix protein level in rheumatic diseases: Potential use as a marker for measuring articular cartilage damage and\/or the therapeutic efficacy of treatments","volume":"1108","author":"Morozzi","year":"2007","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1074\/mcp.M111.013417_bib40","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/art.11287","article-title":"Galectin 3 and its binding protein in rheumatoid arthritis","volume":"48","author":"Ohshima","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1074\/mcp.M111.013417_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1937-6448(08)00602-3","article-title":"Role of proteasomes in cellular regulation","volume":"267","author":"Konstantinova","year":"2008","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"10.1074\/mcp.M111.013417_bib42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nri2423","article-title":"New regulators of NF-\u03baB in inflammation","volume":"8","author":"Ghosh","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1074\/mcp.M111.013417_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1742-7843.2007.00158.x","article-title":"Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-\u03baB in interleukin-1\u03b2-stimulated chondrocytes","volume":"102","author":"Jomphe","year":"2008","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1074\/mcp.M111.013417_bib44","first-page":"125","article-title":"Tenascin in connective tissue development and pathogenesis","volume":"2","author":"Mackie","year":"1994","journal-title":"Perspect. Dev. Neurobiol."},{"key":"10.1074\/mcp.M111.013417_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.joca.2007.06.005","article-title":"Differential proteome analysis of normal and osteoarthritic chondrocytes reveals distortion of vimentin network in osteoarthritis","volume":"16","author":"Lambrecht","year":"2008","journal-title":"Osteoarthr. Cartil."},{"key":"10.1074\/mcp.M111.013417_bib46","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1074\/jbc.M108285200","article-title":"The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor","volume":"277","author":"Bengtsson","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1074\/mcp.M111.013417_bib47","first-page":"RA277","article-title":"The role of connective tissue growth factor in skeletal growth and development","volume":"12","author":"Kanaan","year":"2006","journal-title":"Med. Sci. Monit."}],"container-title":["Molecular &amp; Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153594762030414X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153594762030414X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M111.013417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:21:05Z","timestamp":1761524465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153594762030414X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S153594762030414X"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m111.013417","relation":{},"ISSN":["1535-9476"],"issn-type":[{"type":"print","value":"1535-9476"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacoproteomic Study of Three Different Chondroitin Sulfate Compounds on Intracellular and Extracellular Human Chondrocyte Proteomes","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M111.013417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"M111.013417"}}